bio2018-mybio-sessionicon-companypres

Verseon Corporation

3:15 PM–3:30 PM Jun 6, 2018 (US - Eastern)

Theater 2, Level 0

Description

Exciting updates on our anticoagulation program including new preclinical data on our lead candidate, VE-1902, which is expected to enter the clinic in mid-2018

Session ID: 21378

Tags